GNCA

Genocea Biosciences, Inc.

Delisted

GNCA was delisted on the 2nd of June, 2022.

33 hedge funds and large institutions have $23.9M invested in Genocea Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
8
Increased
5
Reduced
9
Closed
8
Calls
$2.79M
Puts
$23K
Net Calls
+$2.76M
Net Calls Change
-$365K
Name Holding Trade Value Shares
Change
Shares
Change %
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$19K +$19K +10,878 New
Victory Capital Management
27
Victory Capital Management
Texas
$12K +$12K +6,512 New
Bank of America
28
Bank of America
North Carolina
$9K
AA
29
AlphaMark Advisors
Kentucky
$9K +$9K +5,153 New
Morgan Stanley
30
Morgan Stanley
New York
$5K +$808 +464 +19%
Citigroup
31
Citigroup
New York
$3K
AWA
32
Artemis Wealth Advisors
New York
$1.96K
DS
33
DRW Securities
Illinois
-$123K -59,265 Closed
Two Sigma Investments
34
Two Sigma Investments
New York
-$45K -21,938 Closed
WS
35
Wedbush Securities
California
-$40K -19,100 Closed
OAM
36
Oxford Asset Management
United Kingdom
-$27K -13,035 Closed
Deutsche Bank
37
Deutsche Bank
Germany
-$21K -10,324 Closed